INFI Annual Revenue
$2.59 M
+$735.00 K+39.56%
31 December 2022
Summary:
As of January 21, 2025, INFI annual revenue is $2.59 million, with the most recent change of +$735.00 thousand (+39.56%) on December 31, 2022. During the last 3 years, it has fallen by -$456.00 thousand (-14.96%).INFI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Revenue
$583.00 K
-$148.00 K-20.25%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly revenue is $583.00 thousand, with the most recent change of -$148.00 thousand (-20.25%) on June 30, 2023. Over the past year, it has dropped by -$103.00 thousand (-15.01%).INFI Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI TTM Revenue
$2.57 M
-$103.00 K-3.85%
30 June 2023
Summary:
As of January 21, 2025, INFI TTM revenue is $2.57 million, with the most recent change of -$103.00 thousand (-3.85%) on June 30, 2023. Over the past year, it has increased by +$352.00 thousand (+15.88%).INFI TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.6% | -15.0% | +15.9% |
| 3 y3 years | -15.0% | +61.9% | +78.5% |
| 5 y5 years | -56.8% | - | -15.8% |
INFI Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -98.4% | -99.6% | -98.5% |
Infinity Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $583.00 K(-20.2%) | $2.57 M(-3.9%) |
| Mar 2023 | - | $731.00 K(+34.6%) | $2.67 M(+3.0%) |
| Dec 2022 | $2.59 M(+39.6%) | $543.00 K(-23.7%) | $2.59 M(+3.7%) |
| Sept 2022 | - | $712.00 K(+3.8%) | $2.50 M(+12.8%) |
| June 2022 | - | $686.00 K(+5.2%) | $2.22 M(+8.5%) |
| Mar 2022 | - | $652.00 K(+44.6%) | $2.04 M(+10.0%) |
| Dec 2021 | $1.86 M(+8.1%) | $451.00 K(+5.4%) | $1.86 M(+0.8%) |
| Sept 2021 | - | $428.00 K(-16.4%) | $1.84 M(-3.6%) |
| June 2021 | - | $512.00 K(+9.6%) | $1.91 M(+8.6%) |
| Mar 2021 | - | $467.00 K(+7.1%) | $1.76 M(+2.3%) |
| Dec 2020 | $1.72 M(-43.6%) | $436.00 K(-12.1%) | $1.72 M(+8.0%) |
| Sept 2020 | - | $496.00 K(+37.8%) | $1.59 M(+10.6%) |
| June 2020 | - | $360.00 K(-15.9%) | $1.44 M(+7.7%) |
| Mar 2020 | - | $428.00 K(+39.0%) | $1.34 M(-56.2%) |
| Dec 2019 | $3.05 M(-86.2%) | $308.00 K(-10.2%) | $3.05 M(+5.6%) |
| Sept 2019 | - | $343.00 K(+33.5%) | $2.89 M(-88.2%) |
| June 2019 | - | $257.00 K(-88.0%) | $24.55 M(+1.1%) |
| Mar 2019 | - | $2.14 M(+1367.1%) | $24.29 M(+9.7%) |
| Dec 2018 | $22.15 M(+269.1%) | $146.00 K(-99.3%) | $22.15 M(+0.7%) |
| Sept 2018 | - | $22.00 M(+266.7%) | $22.00 M(+266.7%) |
| Dec 2017 | $6.00 M(-68.0%) | - | - |
| Sept 2017 | - | $6.00 M(-36.6%) | $6.00 M(-94.9%) |
| Dec 2016 | $18.72 M(-82.8%) | - | - |
| June 2016 | - | $9.47 M(+2.3%) | $118.55 M(+4.0%) |
| Mar 2016 | - | $9.26 M(+1.9%) | $113.96 M(+4.5%) |
| Dec 2015 | $109.07 M(-33.9%) | $9.08 M(-90.0%) | $109.06 M(+4.5%) |
| Sept 2015 | - | $90.74 M(+1759.5%) | $104.34 M(-40.1%) |
| June 2015 | - | $4.88 M(+11.8%) | $174.24 M(+2.9%) |
| Mar 2015 | - | $4.36 M(+0.2%) | $169.36 M(+2.6%) |
| Dec 2014 | $165.00 M(+250.2%) | $4.36 M(-97.3%) | $165.00 M(+2.7%) |
| Sept 2014 | - | $160.64 M(+633.1%) | $160.64 M(+73.2%) |
| Dec 2012 | $47.11 M(-49.2%) | - | - |
| June 2012 | - | $21.91 M(-13.1%) | $92.74 M(+2.2%) |
| Mar 2012 | - | $25.20 M(+12.9%) | $90.79 M(-2.1%) |
| Dec 2011 | $92.77 M(+30.1%) | $22.32 M(-4.2%) | $92.77 M(+10.1%) |
| Sept 2011 | - | $23.30 M(+16.8%) | $84.29 M(+1.0%) |
| June 2011 | - | $19.96 M(-26.6%) | $83.48 M(+1.5%) |
| Mar 2011 | - | $27.19 M(+96.4%) | $82.22 M(+15.3%) |
| Dec 2010 | $71.33 M | $13.84 M(-38.5%) | $71.33 M(-0.8%) |
| Sept 2010 | - | $22.50 M(+20.3%) | $71.89 M(+13.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | $18.69 M(+14.7%) | $63.17 M(+9.6%) |
| Mar 2010 | - | $16.30 M(+13.2%) | $57.64 M(+13.5%) |
| Dec 2009 | $50.77 M(-39.2%) | $14.40 M(+4.5%) | $50.77 M(-50.9%) |
| Sept 2009 | - | $13.78 M(+4.6%) | $103.42 M(+12.2%) |
| June 2009 | - | $13.17 M(+39.6%) | $92.14 M(+13.1%) |
| Mar 2009 | - | $9.43 M(-85.9%) | $81.48 M(-2.4%) |
| Dec 2008 | $83.44 M(+240.1%) | $67.05 M(+2582.0%) | $83.44 M(+285.4%) |
| Sept 2008 | - | $2.50 M(0.0%) | $21.65 M(-18.8%) |
| June 2008 | - | $2.50 M(-78.1%) | $26.66 M(-10.6%) |
| Mar 2008 | - | $11.39 M(+116.6%) | $29.81 M(+21.5%) |
| Dec 2007 | $24.54 M(+32.7%) | $5.26 M(-29.9%) | $24.54 M(-13.1%) |
| Sept 2007 | - | $7.51 M(+32.8%) | $28.24 M(+5.6%) |
| June 2007 | - | $5.65 M(-7.5%) | $26.73 M(+11.9%) |
| Mar 2007 | - | $6.12 M(-31.7%) | $23.89 M(+29.2%) |
| Dec 2006 | $18.49 M(+3444.4%) | $8.96 M(+49.4%) | $18.49 M(+94.0%) |
| Sept 2006 | - | $6.00 M(+112.8%) | $9.53 M(+169.5%) |
| June 2006 | - | $2.82 M(+292.1%) | $3.54 M(+392.1%) |
| Mar 2006 | - | $718.80 K(-89.3%) | $718.80 K(-97.8%) |
| Dec 2005 | $521.80 K(-99.0%) | - | - |
| Mar 2005 | - | $6.73 M(-46.5%) | $32.31 M(-37.7%) |
| Sept 2004 | - | $12.58 M(-3.3%) | $51.85 M(+2.3%) |
| June 2004 | - | $13.00 M(+10.1%) | $50.68 M(+3.6%) |
| Mar 2004 | - | $11.81 M(-18.4%) | $48.93 M(-1.8%) |
| Dec 2003 | $49.83 M(+20.6%) | $14.47 M(+26.8%) | $49.83 M(+4.4%) |
| Sept 2003 | - | $11.41 M(+1.4%) | $47.72 M(+1.8%) |
| June 2003 | - | $11.25 M(-11.5%) | $46.85 M(+6.5%) |
| Mar 2003 | - | $12.70 M(+2.8%) | $44.00 M(+6.5%) |
| Dec 2002 | $41.31 M(+0.4%) | $12.36 M(+17.2%) | $41.31 M(+3.6%) |
| Sept 2002 | - | $10.54 M(+25.6%) | $39.88 M(+2.3%) |
| June 2002 | - | $8.40 M(-16.2%) | $38.97 M(-6.4%) |
| Mar 2002 | - | $10.02 M(-8.2%) | $41.63 M(+1.2%) |
| Dec 2001 | $41.13 M(+13.4%) | $10.92 M(+13.3%) | $41.13 M(-1.2%) |
| Sept 2001 | - | $9.64 M(-12.8%) | $41.62 M(-1.2%) |
| June 2001 | - | $11.05 M(+16.0%) | $42.14 M(+3.8%) |
| Mar 2001 | - | $9.52 M(-16.5%) | $40.61 M(+12.0%) |
| Dec 2000 | $36.26 M(+177.3%) | $11.40 M(+12.2%) | $36.26 M(+45.9%) |
| Sept 2000 | - | $10.16 M(+6.6%) | $24.86 M(+69.1%) |
| June 2000 | - | $9.53 M(+84.2%) | $14.70 M(+184.2%) |
| Mar 2000 | - | $5.17 M | $5.17 M |
| Dec 1999 | $13.08 M | - | - |
FAQ
- What is Infinity Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual revenue year-on-year change?
- What is Infinity Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly revenue year-on-year change?
- What is Infinity Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals TTM revenue year-on-year change?
What is Infinity Pharmaceuticals annual revenue?
The current annual revenue of INFI is $2.59 M
What is the all time high annual revenue for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual revenue is $165.00 M
What is Infinity Pharmaceuticals annual revenue year-on-year change?
Over the past year, INFI annual revenue has changed by +$735.00 K (+39.56%)
What is Infinity Pharmaceuticals quarterly revenue?
The current quarterly revenue of INFI is $583.00 K
What is the all time high quarterly revenue for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly revenue is $160.64 M
What is Infinity Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, INFI quarterly revenue has changed by -$103.00 K (-15.01%)
What is Infinity Pharmaceuticals TTM revenue?
The current TTM revenue of INFI is $2.57 M
What is the all time high TTM revenue for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high TTM revenue is $174.24 M
What is Infinity Pharmaceuticals TTM revenue year-on-year change?
Over the past year, INFI TTM revenue has changed by +$352.00 K (+15.88%)